Oct 9, 2024, 11:08
Stereotactic Ablative Radiation trial results published in Red Journal – ESTRO
European Society for Radiotherapy & Oncology (ESTRO) posted the following on LinkedIn:
“Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial, published in the Red Journal.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 9, 2024, 12:36
Oct 9, 2024, 12:05
Oct 9, 2024, 11:35
Oct 9, 2024, 11:30